EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Whole-genome sequencing of Acinetobacter baumannii clinical isolates from a tertiary hospital in Terengganu, Malaysia (2011–2020), revealed the predominance of the Global Clone 2 lineage

Nurul Saidah Din, Farahiyah Mohd Rani, Ahmed Ghazi Alattraqchi, Salwani Ismail, Nor Iza A Rahman, David W Cleary, Stuart C Clarke, Chew Chieng Yeo

Microbial Genomics · 05.02.2025 · 11 (2)

DOI: 10.1099/mgen.0.001345 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Genomics, erschienen am 05.02.2025. Verfasst von Nurul Saidah Din und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Research in Infectious Diseases and Biotechnology, Faculty of Medicine, Universiti Sultan Zainal Abidin, Kuala Terengganu, Malaysia. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Whole Genome Sequencing, Acinetobacter Infections. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kementerian Pendidikan Malaysia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carbapenem-resistant Acinetobacter baumannii is recognized by the World Health Organization (WHO) as one of the top priority pathogens. Despite its public health importance, genomic data of clinical isolates from Malaysia remain scarce. In this study, whole-genome sequencing was performed on 126 A . baumannii isolates collected from the main tertiary hospital in the state of Terengganu, Malaysia, over a 10-year period (2011–2020). Antimicrobial susceptibilities determined for 20 antibiotics belonging to 8 classes showed that 77.0% ( n =97/126) of the isolates were categorized as multidrug resistant (MDR), with all MDR isolates being carbapenem resistant. Multilocus sequence typing analysis categorized the Terengganu A. baumannii clinical isolates into 34 Pasteur and 44 Oxford sequence types (STs), with ST2 Pasteur of the Global Clone 2 lineage identified as the dominant ST ( n =76/126; 60.3%). The ST2 Pasteur isolates could be subdivided into six Oxford STs with the majority being ST195 Oxford ( n =35) and ST208 Oxford ( n =17). Various antimicrobial resistance genes were identified with the bla OXA-23 -encoded carbapenemase being the predominant acquired carbapenemase gene ( n =90/126; 71.4%). Plasmid-encoded rep genes were identified in nearly all ( n =122/126; 96.8%) of the isolates with the majority being Rep_3 family ( n =121). Various virulence factors were identified, highlighting the pathogenic nature of this bacterium. Only 14/126 (11.1%) of the isolates were positive for the carriage of CRISPR-Cas arrays with none of the prevalent ST2 Pasteur isolates harbouring them. This study provided a genomic snapshot of the A. baumannii isolates obtained from a single tertiary healthcare centre in Malaysia over a 10-year period and showed the predominance of a single closely related ST2 Pasteur lineage, indicating the entrenchment of this clone in the hospital.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniiWhole Genome SequencingAcinetobacter InfectionsMalaysiaHumansTertiary Care CentersDrug Resistance, Multiple, BacterialMultilocus Sequence TypingMicrobial Sensitivity TestsAnti-Bacterial AgentsGenome, Bacterialbeta-LactamasesCarbapenems

Stichwörter der Autor:innen

Acinetobacter baumanniiGC2 lineageMalaysiagenome sequencingmultidrug resistant

Substanzen

Anti-Bacterial Agentsbeta-LactamasesCarbapenems

Autor:innen und Institutionen

  • Centre for Research in Infectious Diseases and Biotechnology, Faculty of Medicine, Universiti Sultan Zainal Abidin, Kuala Terengganu, Malaysia.
  • Department of Microbes, Infections and Microbiomes, School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, UK.
  • Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
  • Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
  • NIHR Southampton Biomedical Research Centre, University Hospital Southampton Foundation NHS Trust, Southampton, UK.
  • Global Health Research Institute, University of Southampton, Southampton, UK.

Förderung

  • Kementerian Pendidikan Malaysia

Zitieren

APA

Din, N. S., Mohd Rani, F., Alattraqchi, A. G., Ismail, S., A Rahman, N. I., Cleary, D. W., Clarke, S. C., & Yeo, C. C. (2025). Whole-genome sequencing of Acinetobacter baumannii clinical isolates from a tertiary hospital in Terengganu, Malaysia (2011–2020), revealed the predominance of the Global Clone 2 lineage. Microbial Genomics, 11(2). https://doi.org/10.1099/mgen.0.001345

Vancouver

Din NS, Mohd Rani F, Alattraqchi AG, Ismail S, A Rahman NI, Cleary DW, et al. Whole-genome sequencing of Acinetobacter baumannii clinical isolates from a tertiary hospital in Terengganu, Malaysia (2011–2020), revealed the predominance of the Global Clone 2 lineage. Microbial Genomics. 2025;11(2). doi:10.1099/mgen.0.001345

BibTeX
@article{Din2025,
  author = {Din, Nurul Saidah and Mohd Rani, Farahiyah and Alattraqchi, Ahmed Ghazi and Ismail, Salwani and A Rahman, Nor Iza and Cleary, David W and Clarke, Stuart C and Yeo, Chew Chieng},
  title = {Whole-genome sequencing of Acinetobacter baumannii clinical isolates from a tertiary hospital in Terengganu, Malaysia (2011–2020), revealed the predominance of the Global Clone 2 lineage},
  journal = {Microbial Genomics},
  year = {2025},
  volume = {11},
  number = {2},
  doi = {10.1099/mgen.0.001345}
}
Kostenlos starten →